Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Medicinaregatan 9A, PO Box 440, SE 405 30, Gothenburg, Sweden.
Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Medicinaregatan 9A, PO Box 440, SE 405 30, Gothenburg, Sweden; Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Pepparedsleden 1, SE 431 53, Mölndal, Sweden.
Exp Eye Res. 2021 Feb;203:108395. doi: 10.1016/j.exer.2020.108395. Epub 2020 Dec 9.
Cataract, the world-leading cause of blindness, is formed when crystallin aggregates cloud the eye lens. We overexpressed PA28αβ, a proteasome activator with properties protective against aggregation and oxidative stress, and examined whether they are less prone to develop cataract arisen from aging and/or hydrogen peroxide (HO) treatment. Another objective of this work was to compare the HO-induced cataracts of mouse lenses ex vivo to cataracts formed upon aging in mice. As part of an aging study of F2 hybrid C57BL/6NxBALB/c mice, ocular lenses of mature adult (7 months), middle-aged (15 months), and old (22 months of age) PA28αOE mice and their wildtype littermates (n = 22-44 lenses per group) were dissected and evaluated with regard to their cataractous state. In parallel, ocular lenses from 3 to 4 months old PA28αOE and wildtype C57BL/6 N littermates were treated with 100 μM HO every 24 h for 7 days, with progression of cataract and physical appearance monitored daily. Lenses from both studies were also subjected to analysis of oxidative protein damage (carbonylation) and protein solubility. We found that overexpression of PA28αβ had no effect on neither age-related nor HO-induced cataract and conclude that overexpression of PA28αβ does not protect mice from developing cataract. The inefficiency of PA28αβ against cataract could be due to its anti-aggregation activity being already excessively present in the eye lens, exerted by crystallins. Crystallins are likely also constituting the 20-25 kDa proteins that were the dominant carbonyl targets in the eye lens irrespective of cataractous state. Assessment of HO-induced cataract in relation to age-related cataract demonstrated that high molecular weight protein carbonylation correlates to cataract both in vivo and ex vivo, while reduced protein solubility is more pronounced in age-related cataract. Furthermore, this work highlights vast dissimilarities in the physical manifestations of cataract upon aging and HO ex vivo treatment. Age-related cataract initiation can take various forms, as a vague general blurriness or as a barely visible demarcated opacity, while HO-induced cataractogenesis seems to follow a specific scheme. In mice, this scheme begins with relatively opaque peripheral areas emerging that clear up later on as the lenses start to display a hat-like appearance. This transformation takes place synchronous to swelling of the eye lens, and is likely a result of osmotic disturbances causing a phase separation between the viscous lens cortex and the more solid fibers of the lens nucleus.
白内障是全球致盲的主要原因,它是由晶状体蛋白聚集导致的。我们过表达了 PA28αβ,一种具有抗聚集和抗氧化应激特性的蛋白酶体激活剂,并研究了它们是否不易发生由衰老和/或过氧化氢 (HO) 处理引起的白内障。这项工作的另一个目的是比较体外 HO 诱导的白内障与小鼠体内衰老形成的白内障。作为 F2 杂交 C57BL/6NxBALB/c 小鼠衰老研究的一部分,成熟成年 (7 个月)、中年 (15 个月) 和老年 (22 个月) PA28αOE 小鼠及其野生型同窝仔鼠的眼球晶状体被解剖出来,并根据白内障状态进行评估。同时,对 3 至 4 个月大的 PA28αOE 和野生型 C57BL/6N 同窝仔鼠的眼球晶状体进行 100μM HO 处理,每 24 小时处理一次,共处理 7 天,每天监测白内障的进展和外观。来自这两项研究的晶状体还进行了氧化蛋白损伤 (羰基化) 和蛋白质可溶性分析。我们发现,PA28αβ 的过表达对年龄相关或 HO 诱导的白内障均无影响,并得出结论,PA28αβ 的过表达并不能保护小鼠免受白内障的发生。PA28αβ 对抗白内障的效率低下可能是由于其抗聚集活性在晶状体中已经过度存在,这是由晶状体蛋白引起的。晶状体蛋白也可能是构成晶状体中 20-25 kDa 大小的主要羰基靶标,无论白内障状态如何都是如此。将 HO 诱导的白内障与年龄相关性白内障进行评估表明,高分子量蛋白羰基化与体内和体外的白内障均相关,而蛋白质可溶性降低在年龄相关性白内障中更为明显。此外,这项工作突出了体内衰老和体外 HO 处理引起的白内障在物理表现上的巨大差异。年龄相关性白内障的发生可以采取多种形式,表现为模糊的一般混浊或几乎不可见的界限分明的不透明,而 HO 诱导的白内障发生似乎遵循一种特定的模式。在小鼠中,这种模式始于相对不透明的外围区域的出现,随着晶状体开始呈现帽子状外观,这些区域后来会变清晰。这种转变与晶状体肿胀同步发生,可能是渗透压紊乱导致粘性晶状体皮质和更固体的晶状体核纤维之间发生相分离的结果。